Evaluation of serum Epstein–Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Hui-Lan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Arthritis, Rheumatoid, Autoimmune Diseases, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Innovative Talents Program of the Eighth Affiliated Hospital, Sun Yat-sen University.
Abstract (Originalsprache)
Systemic autoimmune diseases (SADs) are a growing spectrum of autoimmune disorders that commonly affect multiple organs. The role of Epstein–Barr virus (EBV) infection or reactivation as a trigger for the initiation and progression of SADs has been established, while the relationship between EBV envelope glycoproteins and SADs remains unclear. Here, we assessed the levels of IgG, IgA, and IgM against EBV glycoproteins (including gp350, gp42, gHgL, and gB) in serum samples obtained from patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and found that RA and SLE patients exhibited a statistically significant increase in the levels of 8 and 11 glycoprotein antibodies, respectively, compared to healthy controls ( p < 0.05). The LASSO model identified four factors as significant diagnostic markers for RA: gp350 IgG, gp350 IgA, gHgL IgM, and gp42 IgA; whereas for SLE it included gp350 IgG, gp350 IgA, gHgL IgA, and gp42 IgM. Combining these selected biomarkers yielded an area under the curve (AUC) of 0.749 for RA and 0.843 for SLE. We subsequently quantified the levels of autoantibodies associated with SADs in mouse sera following immunization with gp350. Remarkably, none of the tested autoantibody levels exhibited statistically significant alterations. Elevation of glycoprotein antibody concentration suggests that Epstein–Barr virus reactivation and replication occurred in SADs patients, potentially serving as a promising biomarker for diagnosing SADs. Moreover, the absence of cross‐reactivity between gp350 antibodies and SADs‐associated autoantigens indicates the safety profile of a vaccine based on gp350 antigen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Gua…
ORCID-Profile: Ai-Xia Zhai, Mu-Sheng Zeng
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Innovative Talents Program of the Eighth Affiliated Hospital, Sun Yat-sen University
Zitieren
APA
Li, H. L., Zhong, L. Y., Kang, Y. F., Yang, Y. L., Shi, L., Zhai, A. X., Wu, C., Zeng, M. S., & Zhu, Q. Y. (2024). Evaluation of serum Epstein–Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases. Journal of Medical Virology. https://doi.org/10.1002/jmv.29595
Vancouver
Li HL, Zhong LY, Kang YF, Yang YL, Shi L, Zhai AX, et al. Evaluation of serum Epstein–Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases. Journal of Medical Virology. 2024. doi:10.1002/jmv.29595
BibTeX
@article{Li2024,
author = {Li, Hui-Lan and Zhong, Lan-Yi and Kang, Yin-Feng and Yang, Yan-Lan and Shi, Liang and Zhai, Ai-Xia and Wu, Chao and Zeng, Mu-Sheng and Zhu, Qian-Ying},
title = {Evaluation of serum Epstein–Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29595}
}
EUVIMED